To address correspondence regarding the incidence, aetiology, and outcomes of ventilator-associated pneumonia (VAP) in Europe, specifically responding to inquiries raised by Ignacio Martin-Loeches and Luis Felipe Reyes.
Approach:
Key Findings:
Gram-negative pathogens are the most common cause of VAP, with S. aureus being the most prevalent species in the POS-VAP cohort.
The proportion of P. aeruginosa VAP varies by region, with higher rates observed in South American cohorts compared to European ones.
Patient demographics, including age, sex, and comorbidities, influence the incidence and type of pathogens causing VAP.
Differences in pathogen distribution exist between early and late VAP cases, with S. aureus predominating in early cases.
Interpretation:
The findings highlight the complexity of VAP aetiology and the importance of region-specific epidemiological data.
Limitations:
Variability in VAP definitions and diagnostic criteria across studies may affect comparability.
The study's focus on first VAP episodes may not represent the full spectrum of VAP cases in ICU settings.
Conclusion:
Understanding regional and demographic variations in VAP pathogens is essential for effective management.
The partner in the next room, the hormone in the blister pack, the cat on the couch, the minute-long chair stand. Several new studies suggest the factor shaping outcomes may be the one clinicians aren’t routinely measuring.
